Page last updated: 2024-09-03

imatinib mesylate and Chloasma

imatinib mesylate has been researched along with Chloasma in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Roeker, LE; Wolanskyj, AP	1
Ergun, T; Eser, A; Kaygusuz Atagunduz, I; Salman, A	1
Lewis, DM	1
Christerson, L; Halbritter, S; Mattsson, U; Mörner Serikoff, E; Warfvinge, G	1
Gilbert, M; Klieb, HB; Sade, S; Wong, M	1
Shere, Y; Vigneswaran, N; Yu, YH	1

Reviews

1 review(s) available for imatinib mesylate and Chloasma

Article	Year
Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature. Dermatology online journal, 2011, May-15, Volume: 17, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Melanosis; Mouth Diseases; Palate, Hard; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2011

Article

Year

Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature.

Dermatology online journal, 2011, May-15, Volume: 17, Issue:5

Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Melanosis; Mouth Diseases; Palate, Hard; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2011

Other Studies

5 other study(ies) available for imatinib mesylate and Chloasma

Article	Year
Imatinib-associated melanosis of the palate. American journal of hematology, 2014, Volume: 89, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanosis; Palate; Piperazines; Pyrimidines	2014
Horizontal melanonychia. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:5 Topics: Aged, 80 and over; Antineoplastic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melanosis; Nail Diseases; Nails, Malformed; Protein Kinase Inhibitors	2017
Diffuse pigmentation of the palate. Journal - Oklahoma Dental Association, 2009, Volume: 100, Issue:8 Topics: Aged; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melanosis; Mouth Mucosa; Palate, Hard; Piperazines; Pyrimidines	2009
Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 111, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanosis; Middle Aged; Palate, Hard; Piperazines; Pyrimidines	2011
Oral and maxillofacial pathology case of the month. Palatal melanosis associated with imatinib mesylate therapy. Texas dental journal, 2012, Volume: 129, Issue:8 Topics: Adult; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melanosis; Mouth Mucosa; Palate, Hard; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines	2012